Star Sports Medicine (1609) Fundamentals 2026 — P/E 6534.0x, Revenue Analysis | SniperIQ

38.80 on the HKSE. This SniperIQ fundamentals page covers Star Sports Medicine's valuation (P/E 6534.0x, P/B 228.2x), profitability (net margin 4.3%), balance-sheet quality, and AI signal context — from live market data, research only.

Full research coverage

• 8-Quarter Revenue & Margin Trend
• Debt Maturity & Coverage
• Peer Valuation Comparison
• Free Cash Flow & Owner Earnings
• AI Signal + Institutional Flow
• DCF Valuation Model

Frequently Asked Questions

What is Star Sports Medicine's market cap?

Star Sports Medicine (1609) has a market capitalization of approximately HK$6.4B, trading at HK

38.80 on the HKSE. Market cap moves with the live share price.

What is Star Sports Medicine's P/E ratio?

Star Sports Medicine's trailing twelve-month P/E ratio is 6534.0x, with a price-to-book (P/B) of 228.2x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.

How profitable is Star Sports Medicine?

Star Sports Medicine runs a net profit margin of 4.3%, a gross margin of 11.2%, and an operating margin of 3.8%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.

Does Star Sports Medicine pay a dividend?

Star Sports Medicine does not currently show a material trailing dividend yield; it is positioned more as a total-return name. Always confirm the latest dividend policy in the company's filings.

Is Star Sports Medicine financially healthy?

Star Sports Medicine carries a debt-to-equity ratio of 0.01x and a current ratio of 5.51x, with a market beta of 0.50. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.

Is Star Sports Medicine a good stock to buy in 2026?

SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Star Sports Medicine (1609) the key facts are: market cap HK$6.4B, P/E 6534.0x, 52-week range 125.1-299. Weigh valuation, profitability, growth, and balance-sheet strength against Healthcare peers and form your own view.